The objective of this study was to compare, at equal blood pressure (BP) reduction, the effect of two different combinations on metabolic control and albumninuria in type 2 diabetic hypertensive patients with albuminuria. This was a prospective, randomised, double-blind, parallel, controlled trial carried out in 11 Spanish hospitals. A total of 103 type 2 diabetic patients with stable albuminuria and BP not controlled on monotherapy were randomised of which 93 finished the study. After a 4-week single-blind placebo period, patients were randomised to verapamil SR/trandolapril 180/2mg (VT) or to enalpril/hydrochlorothiazide 20/12.5mg (EH). Treatment duration was 6 months. The main outcome measures were changes in BP 24-h albuminuria, blood glucose and glycated haemoglobin. Overall BP was significantly reduced from 157.3±12.0/98.3±6.4 mm Hg to 140.5±14.5/86.1±8.1 nun Hg (P